Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Vitamin B12(Cobalamin) market: $126 Mn against $24 Mn in 2023, about 5.2 times as large.
China grows faster: 7% a year, against 3.5%. The gap still grows from $102 Mn to $130 Mn by 2033.
Clinical research: 39 active trials in the US, 24 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $126 Mn | $24 Mn |
| Market size, 2033 projected | $178 Mn | $47 Mn |
| Growth a year (CAGR) | 3.5% | 7% |
| Money added, 2023–2033 | $52 Mn | $23 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $0.37 | $0.02 |
| Active clinical trials | 39 | 24 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Vitamin B12(Cobalamin) market: $126 Mn against $24 Mn in 2023, about 5.2 times as large.
China grows faster: 7% a year, against 3.5%. The gap still grows from $102 Mn to $130 Mn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.